Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2009
11/10/2009CA2416785C Novel arylethene-sulfonamides
11/10/2009CA2382117C 4-substituted piperidine compound
11/10/2009CA2378792C Aminothiazole derivatives and their use as crf receptor ligands
11/10/2009CA2353460C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
11/05/2009WO2009134616A2 Novel inhibitors of hepatitis c virus replication
11/05/2009WO2009134392A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009WO2009134384A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009WO2009133970A1 Crystalline compound
11/05/2009WO2009133861A1 Cyclic amine compound
11/05/2009WO2009133834A1 Keto-amide derivative having inhibitory activity on endothelial lipase
11/05/2009WO2009133831A1 Phenylpropionic acid derivative and use thereof
11/05/2009WO2009133687A1 Cyclopentylacrylic acid amide derivative
11/05/2009WO2009133576A1 A process for the preparation of 4-[2-(5-ethyl-2-pyridyl)ethoxy]nitrobenzene and pioglitazone
11/05/2009WO2009133522A1 Piperidine and pyrrolidine compounds
11/05/2009WO2009133348A1 Aminopyridine derivatives
11/05/2009WO2009133127A1 Fused bicyclic compounds and use thereof as pi3k inhibitors
11/05/2009WO2009132785A1 Thiazol-4-carboxylic acid esters and thioesters as plant protection agents
11/05/2009WO2009085226A3 Inhibitors of cdc2-like kinases (clks) and methods of use thereof
11/05/2009WO2009013122A3 Azo dyes
11/05/2009US20090275751 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
11/05/2009US20090275747 Methods for the preparation of salts of 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxyl]ethanol (quetiapine) and for the purification thereof
11/05/2009US20090275625 5-[4-(2-hydroxy-ethoxy)-benz[Z]ylidene]-2-([Z]-isopropylimino)-3-phenyl-thiazolidin-4-one; {2-[4-(2-([Z]-isopropylimino)-4-oxo-3-phenyl-thiazolidin-5-[Z]-ylidenemethyl)-phenoxy]-ethoxy}-acetic acid; immunosuppressant agents; multiple sclerosis, psoriasis
11/05/2009US20090275624 Inhibitors of cdc phosphatases
11/05/2009US20090275621 peroxisome proliferator-activated receptors (PPAR) modulators such as 5-(4-{2-[5-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-4-yl]-ethoxy}-phenyl)-3H-[1,3,4]oxadiazol-2-one, used for the treatment of demyelinating diseases and disorders of fatty acid metabolism and glucose utilization
11/05/2009US20090275588 Novel sulfonamide compounds
11/05/2009US20090275569 Benzotriazine Inhibitors of Kinases
11/05/2009US20090275568 Fused quinoline derivative and use thereof
11/05/2009US20090275567 2-heterocycloamino-4-imidazolylpyrimidines as agents for the inhibition of cell proliferation
11/05/2009US20090275566 Bace inhibitors
11/05/2009US20090275557 Novel Composition for Treatment of Diseases Related to Activated Lymphocytes
11/05/2009US20090275550 2-(4-isopropenylphenyl)-N-[(1R)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide; epilepsy, pain, neuropathic pain, schizophrenia, Parkinson's disease, depression, anxiety, sleep disorders, psychosis, schizophrenia, cardiac arrhythmia and hypertension
11/05/2009US20090275538 Arylmethylidene heterocycles as novel analgesics
11/05/2009US20090275037 Fluorescent double stranded dna binding dyes
11/05/2009US20090274656 Hepatitis c virus inhibitors
11/05/2009US20090274655 2-carboxy thiophene derivatives as anti viral agents
11/05/2009CA2723039A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009CA2723032A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009CA2722775A1 Thiazol-4-carboxylic acid esters and thioesters as plant protection agents
11/05/2009CA2722733A1 Cyclopentylacrylamide derivative
11/05/2009CA2722648A1 Aminopyridine derivatives
11/05/2009CA2722347A1 Piperidine and pyrrolidine compounds
11/05/2009CA2720846A1 Novel inhibitors of hepatitis c virus replication
11/04/2009EP2112880A2 Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment
11/04/2009EP1720868B1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
11/04/2009EP1651642B1 Pna monomer and precursor
11/04/2009EP1499311B1 Substituted benzazoles and use thereof as raf kinase inhibitors
11/04/2009EP1311488B1 Substituted imidazoles as tafia inhibitors
11/04/2009EP1303488B1 Piperidine compounds for use as ccr-3 inhibitors
11/04/2009CN101573357A 吲哚化合物 Indole compound
11/04/2009CN101573356A Modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
11/04/2009CN101573343A HIV inhibiting 6-substituted pyrimidines
11/04/2009CN101573342A HIV inhibiting 5,6-substituted pyrimidines
11/04/2009CN101573339A Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation
11/04/2009CN101570517A 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
11/03/2009US7612201 Pyrazole compounds
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
11/03/2009US7612091 Caspase inhibitors and uses thereof
11/03/2009US7612088 Heterocyclic compounds and their use as aldosterone synthase inhibitors
11/03/2009US7612075 Anticaogulants; cardiovascular disorders
11/03/2009US7612070 Indole derivative having heterocycle and mono- or diazaindole derivative
11/03/2009US7612067 Imidazopyridazine compounds
11/03/2009US7612059 Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use
11/03/2009CA2474510C Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/03/2009CA2442423C Therapeutic drug for psychoneurotic disorders
11/03/2009CA2341291C Pyridine ketones useful as herbicides
10/2009
10/29/2009WO2009132310A1 Inhibitors of udp-galactopyranose mutase thwart mycobacterial growth
10/29/2009WO2009132136A1 Carboxamide compounds for the treatment of metabolic disorders
10/29/2009WO2009131669A2 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
10/29/2009WO2009131196A1 Substituted pyrrolidine derivative and use thereof
10/29/2009WO2009131173A1 2-aminoquinazoline derivative
10/29/2009WO2009131171A1 Novel five-membered ring compound
10/29/2009WO2009131170A1 Five-membered ring compound
10/29/2009WO2009131096A1 Compound having npy y5 receptor antagonist activity
10/29/2009WO2009130900A1 Oxime derivative, intermediate compound, and plant disease control agent
10/29/2009WO2009130496A1 Substituted pyrimidin-5-carboxamides 281
10/29/2009WO2009130242A1 Low molecular weight derivatives and use thereof in treatment of prostaglandin e synthase related diseases
10/29/2009WO2009130193A1 Fungicide hydroximoyl-heterocycles derivatives
10/29/2009WO2009129696A1 A kind of receptor signaling transoluction positive modulators, preparation methods and uses thereof
10/29/2009WO2009106980A3 Indazole derivatives
10/29/2009WO2009094407A3 Fungicidal amides
10/29/2009US20090270630 Process for the synthesis of benzylidene rosiglitazone base
10/29/2009US20090270627 4-Ethynyl (1,2-dicyanobenzene)-4'-Ethynylphenyl-1(4,5-dicyanobenzene); 1,4-Bis(4-pyridyl)butadiyne; 4-ethynyl(pyridine)-4'-ethynylnaphthalene-1-pyridine; self-assembled mono-, multilayers/ supramolecular objects; three-terminal devices; logic switches;nanoelectronic ; computers; wires; dielectrics
10/29/2009US20090270621 N-4-[3-Chloro-4-(3-fluoro-benzyloxy)-phenyl]-N6-(3-ethyl-oxazolidin-2-ylidene)-quinazoline-4,6-diamine; use as type I receptor tyrosine kinase inhibitor; hyperproliferation diseases such as cancer; antiinflammatory agents
10/29/2009US20090270468 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
10/29/2009US20090270466 Epothilones C, D, E, and F, Preparation and Compositions
10/29/2009US20090270457 6,11-bicyclolides: bridged biaryl macrolide derivatives
10/29/2009US20090270456 Novel chemical compounds
10/29/2009US20090270454 Sulfonamide containing compounds for treatment of inflammatory disorders
10/29/2009US20090270446 Diamine derivatives
10/29/2009US20090270407 Fungicidal isoxazolidines
10/29/2009US20090270374 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
10/29/2009US20090270367 Substituted hydroxyethylamine aspartyl protease inhibitors
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009US20090270363 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof
10/29/2009DE102008020785A1 Verwendung von 5-Amino-1,2,4-thiadiazol zur Hemmung bzw. Steuerung der Nitrifikation Use of 5-amino-1,2,4-thiadiazol for inhibiting or controlling the nitrification
10/29/2009CA2722159A1 Substituted phenylimidazole compounds and their use as ido inhibitors
10/29/2009CA2722139A1 Carboxamide compounds for the treatment of metabolic disorders
10/29/2009CA2722041A1 Novel five-membered ring compound
10/29/2009CA2722007A1 Five-membered ring compound
10/29/2009CA2721750A1 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
1 ... 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 ... 628